[{"ID":"6810_15-2021_NCT02205125","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible\n\nThe patient is not eligible for the clinical trial because the trial is focused on colonoscopy and polypectomy, and the patient does not have a colonoscopy scheduled. Additionally, the patient is 70 years old, which is outside of the age range of 18-65 years specified in the exclusion criteria.","PROBA":0.9827467247},{"ID":"30737_65-2021_NCT02287506","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9842505828},{"ID":"5294_12-2021_NCT01305148","TOPIC_YEAR":2021,"RESPONSE":"#1: No, the patient is not eligible for the clinical trial because the patient has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which are not related to warfarin sensitivity or therapy initiation. The clinical trial is focused on the use of genetic information related to warfarin sensitivity, and the patient's condition is not relevant to this focus.\n\n#2: Yes, the patient is eligible for the clinical trial because the patient has a known genetic predisposition to warfarin sensitivity, which is the focus of the clinical trial. The patient's history of gestational diabetes mellitus, hypertension with pregnancy, and obesity may also be relevant to the study, as these conditions can affect warfarin metabolism and response.\n\n#3: No, the patient is not eligible for the clinical trial because the patient is under the age of 18, and the clinical trial is only open to adults.\n\n#4: Yes, the patient is eligible for the clinical trial because the patient has a known genetic predisposition to warfarin sensitivity, which is the focus of the clinical trial. The patient's history of gestational diabetes mellitus, hypertension with pregnancy, and obesity may also be relevant to the study, as these conditions can affect warfarin metabolism and response. Additionally, the patient's Marfan's syndrome and severe mitral valve prolapse with regurgitation may also be relevant to the study, as these conditions can affect the patient's risk of bleeding complications.","PROBA":0.9882867997},{"ID":"6767_15-2021_NCT01903148","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9923629463},{"ID":"35514_75-2021_NCT02098642","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n\nThe patient is eligible for the clinical trial because they have been diagnosed with Parkinson's disease, which is the condition being studied in the trial. The patient's symptoms of slowness of movement and tremors are also consistent with the motor symptoms of Parkinson's disease. Additionally, the patient does not have any of the exclusion criteria listed in the trial, such as atypical parkinsonism, other concomitant neurological conditions, joint disorders, muscle disorders, or other orthopedic conditions. Therefore, the patient is eligible to participate in the clinical trial.","PROBA":0.9811105448},{"ID":"5456_12-2021_NCT03453853","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9490769431},{"ID":"30755_65-2021_NCT02411578","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n\nThe patient is eligible for the clinical trial because they have type 1 diabetes, which meets the inclusion criterion of having type 1 diabetes. Additionally, the patient does not have any of the exclusion criteria, such as a history of severe hypoglycemic episodes or other medical conditions that could interfere with the study.","PROBA":0.9833215174},{"ID":"35435_75-2021_NCT01399905","TOPIC_YEAR":2021,"RESPONSE":"#A: Eligible\n\nThe patient is eligible for the clinical trial because they have been diagnosed with Parkinson's disease, which is the condition being studied in the trial. Additionally, the patient does not have any of the exclusion criteria, such as dementia or hallucinations, that would prevent them from participating in the trial.","PROBA":0.9970553748},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial.\n\n#2: No, the patient is not eligible for the clinical trial.\n\n#3: The patient is not eligible for the clinical trial because of the exclusion criteria.\n\n#4: The patient is eligible for the clinical trial, but only for the resistance training modality.\n\n#5: The patient is eligible for the clinical trial, but only for the aerobic training modality.","PROBA":0.9780500129},{"ID":"17065_36-2021_NCT01737138","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n\nThe patient is not eligible for the clinical trial because the trial is focused on patients with chronic kidney disease and resistant hypertension, and the patient does not have these conditions. The patient is obese and has sleep apnea, PCO, and dissatisfaction with their body shape, but these conditions are not related to the trial's inclusion criteria.","PROBA":0.9950408705},{"ID":"6652_15-2021_NCT00921856","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n\nThe patient is not eligible for the clinical trial because the trial is focused on patients with suspected coronary artery disease (CAD), and the patient's diagnosis is pancreatic adenocarcinoma. The patient's age (70 years old) and other medical conditions (such as hypertension, hyperlipidemia, and chronic kidney disease) do not exclude them from the trial.","PROBA":0.9811381327},{"ID":"30417_65-2021_NCT00211510","TOPIC_YEAR":2021,"RESPONSE":"# Eligibility\n\nBased on the patient's information, the patient is eligible for the clinical trial because:\n\n* The patient has type 1 diabetes, which is an inclusion criterion for the study.\n* The patient is currently using an insulin pump, which is an inclusion criterion for the study.\n* The patient does not have any of the exclusion criteria, such as pregnancy or a history of unresolved tape allergy or skin conditions.\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9887264287},{"ID":"5322_12-2021_NCT01740583","TOPIC_YEAR":2021,"RESPONSE":"#PatientEligibility\n\nBased on the patient note and the inclusion and exclusion criteria for the clinical trial, the patient is not eligible for the study. The patient has a history of gestational diabetes mellitus, hypertension with pregnancy, and obesity, which are all exclusion criteria for the study. Additionally, the patient has a known history of mitral valve prolapse with regurgitation, which is not within the scope of the study. The study is focused on treating functional mitral valve regurgitation, and the patient's condition is not within that scope.\n\nTherefore, the patient is not eligible for the clinical trial.","PROBA":0.9869767812},{"ID":"30870_65-2021_NCT03605979","TOPIC_YEAR":2021,"RESPONSE":"#1: Yes, the patient is eligible for the clinical trial because they have type 1 diabetes, which is one of the inclusion criteria.\n\n#2: No, the patient is not eligible for the clinical trial because they do not have hypoglycemia unawareness, which is one of the exclusion criteria.\n\n#3: Yes, the patient is eligible for the clinical trial because they are > 18 years old and do not have any serious diseases that could interfere with the study.\n\n#4: No, the patient is not eligible for the clinical trial because they do not have hearing loss or low vision, which are exclusion criteria.\n\n#5: Yes, the patient is eligible for the clinical trial because they have a history of type 1 diabetes and are using insulin and vitamin D supplements, which meet the inclusion criteria.","PROBA":0.988965787},{"ID":"6731_15-2021_NCT01611532","TOPIC_YEAR":2021,"RESPONSE":"#A: Eligible\n\nBased on the patient's note, the patient is eligible for the clinical trial because the patient has acute pancreatitis, which is one of the inclusion criteria for the study. Additionally, the patient's age (70 years old) and gender (female) meet the inclusion criteria. The patient's recent history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia are not relevant to the study, as they are not exclusion criteria. Therefore, the patient is eligible for the clinical trial.","PROBA":0.9810406004},{"ID":"6832_15-2021_NCT02426944","TOPIC_YEAR":2021,"RESPONSE":"#1: No, the patient is not eligible for the clinical trial because she has a history of CAD and pancreatic adenocarcinoma, which are not included in the inclusion criteria.\n\n#2: Yes, the patient is eligible for the clinical trial because she has atrial fibrillation, which is included in the inclusion criteria.\n\n#3: No, the patient is not eligible for the clinical trial because she has a history of stroke and acute coronary syndrome, which are excluded in the exclusion criteria.\n\n#4: Yes, the patient is eligible for the clinical trial because she has a history of hyperlipidemia and hypertension, which are not excluded in the exclusion criteria.","PROBA":0.9958124597},{"ID":"6724_15-2021_NCT01534754","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible\n\nThe patient is eligible for the clinical trial because she has a history of CAD and recent abdominal mass with fevers and bandemia, which are symptoms of diverticular disease. The patient's recent history of diverticulitis is also a inclusion criterion for the trial. Additionally, the patient's other medical conditions, such as coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, are not exclusion criteria for the trial. Therefore, the patient meets all the inclusion criteria and none of the exclusion criteria, making her eligible for the clinical trial.","PROBA":0.9891319301},{"ID":"6816_15-2021_NCT02243007","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.8770594802},{"ID":"5517_12-2021_NCT04156295","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9727362618},{"ID":"7077_15-2021_NCT04600063","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible\n\nThe patient is eligible for the clinical trial because they have a diagnosis of pancreatic adenocarcinoma, which is an invasive ductal carcinoma of the pancreas, and they are undergoing distal pancreatectosplenectomy. The patient meets all of the inclusion criteria, such as having invasive pancreatic ductal carcinoma, and does not have any of the exclusion criteria, such as severe ischemic heart disease or active hepatitis. Therefore, the patient is eligible for the clinical trial.","PROBA":0.998355861}]
